home / stock / repl / repl articles

REPL Articles, Replimune Group Inc.

Stock Information
Company Name: Replimune Group Inc.
Stock Symbol: REPL
Market: NASDAQ
Website: replimune.com
Menu
REPL REPL Quote REPL Short REPL News REPL Articles REPL Message Board
Get REPL Alerts

News, Short Squeeze, Breakout and More Instantly...
Replimune Announces $100 Million Private Placement Financing | Benzinga

- Led by a life-sciences focused institutional investor, with participation from Redmile Group, RTW Investments, Boxer Capital and other institut...
Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session | Benzinga

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Friday. Shares of Vail Resorts, Inc. (NYSE:MTN) f...

Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

WOBURN, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the deve...

Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarte...
Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings | Benzinga

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Thursday. The Dow traded up 0.14% to 38,860.4...

Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday? | Benzinga

Thursday, Replimune Group Inc (NASDAQ:REPL) released topline results from the primary analysis of the IGNYTE clinical trial of RP1 plus nivolumab i...

J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Thursday. Shares of The J. M. Smucker Company (NYSE:SJM) rose sha...
Replimune Presents Positive Data from RP1 and RP2 Clinical Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | Benzinga

-- Investigator-assessed 12-month results from the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD-1 failed melanoma demonstrate an overall...

Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | Benzinga

WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the develo...

Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions | Benzinga

Philip Astley-Sparke to transition from current role of CEO to Executive Chairman Planned leadership changes position the Company for commercializ...
Next 10